Detection of <i>EGFR</i> Mutations Using Bronchial Washing-Derived Extracellular Vesicles in Patients with Non-Small-Cell Lung Carcinoma

The detection of epidermal growth factor receptor (<i>EGFR</i>) mutation, based on tissue biopsy samples, provides a valuable guideline for the prognosis and precision medicine in patients with lung cancer. In this study, we aimed to examine minimally invasive bronchial washing (BW)-deri...

Full description

Bibliographic Details
Main Authors: Juhee Park, Chaeeun Lee, Jung Seop Eom, Mi-Hyun Kim, Yoon-Kyoung Cho
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/10/2822
_version_ 1797552130150629376
author Juhee Park
Chaeeun Lee
Jung Seop Eom
Mi-Hyun Kim
Yoon-Kyoung Cho
author_facet Juhee Park
Chaeeun Lee
Jung Seop Eom
Mi-Hyun Kim
Yoon-Kyoung Cho
author_sort Juhee Park
collection DOAJ
description The detection of epidermal growth factor receptor (<i>EGFR</i>) mutation, based on tissue biopsy samples, provides a valuable guideline for the prognosis and precision medicine in patients with lung cancer. In this study, we aimed to examine minimally invasive bronchial washing (BW)-derived extracellular vesicles (EVs) for <i>EGFR</i> mutation analysis in patients with lung cancer. A lab-on-a-disc equipped with a filter with 20-nm pore diameter, Exo-Disc, was used to enrich EVs in BW samples. The overall detection sensitivity of <i>EGFR</i> mutations in 55 BW-derived samples was 89.7% and 31.0% for EV-derived DNA (EV-DNA) and EV-excluded cell free-DNA (EV-X-cfDNA), respectively, with 100% specificity. The detection rate of T790M in 13 matched samples was 61.5%, 10.0%, and 30.8% from BW-derived EV-DNA, plasma-derived cfDNA, and tissue samples, respectively. The acquisition of T790M resistance mutation was detected earlier in BW-derived EVs than plasma or tissue samples. The longitudinal analysis of BW-derived EVs showed excellent correlation with the disease progression measured by CT images. The <i>EGFR</i> mutations can be readily detected in BW-derived EVs, which demonstrates their clinical potential as a liquid-biopsy sample that may aid precise management, including assessment of the treatment response and drug resistance in patients with lung cancer.
first_indexed 2024-03-10T15:55:35Z
format Article
id doaj.art-19366d0d76b5443a8196852aa08845c2
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T15:55:35Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-19366d0d76b5443a8196852aa08845c22023-11-20T15:38:46ZengMDPI AGCancers2072-66942020-09-011210282210.3390/cancers12102822Detection of <i>EGFR</i> Mutations Using Bronchial Washing-Derived Extracellular Vesicles in Patients with Non-Small-Cell Lung CarcinomaJuhee Park0Chaeeun Lee1Jung Seop Eom2Mi-Hyun Kim3Yoon-Kyoung Cho4Center for Soft and Living Matter, Institute for Basic Science (IBS), Ulsan 44919, KoreaCenter for Soft and Living Matter, Institute for Basic Science (IBS), Ulsan 44919, KoreaDepartment of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, 179, Gudeok-ro, Seo-Gu, Busan 49241, KoreaDepartment of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, 179, Gudeok-ro, Seo-Gu, Busan 49241, KoreaCenter for Soft and Living Matter, Institute for Basic Science (IBS), Ulsan 44919, KoreaThe detection of epidermal growth factor receptor (<i>EGFR</i>) mutation, based on tissue biopsy samples, provides a valuable guideline for the prognosis and precision medicine in patients with lung cancer. In this study, we aimed to examine minimally invasive bronchial washing (BW)-derived extracellular vesicles (EVs) for <i>EGFR</i> mutation analysis in patients with lung cancer. A lab-on-a-disc equipped with a filter with 20-nm pore diameter, Exo-Disc, was used to enrich EVs in BW samples. The overall detection sensitivity of <i>EGFR</i> mutations in 55 BW-derived samples was 89.7% and 31.0% for EV-derived DNA (EV-DNA) and EV-excluded cell free-DNA (EV-X-cfDNA), respectively, with 100% specificity. The detection rate of T790M in 13 matched samples was 61.5%, 10.0%, and 30.8% from BW-derived EV-DNA, plasma-derived cfDNA, and tissue samples, respectively. The acquisition of T790M resistance mutation was detected earlier in BW-derived EVs than plasma or tissue samples. The longitudinal analysis of BW-derived EVs showed excellent correlation with the disease progression measured by CT images. The <i>EGFR</i> mutations can be readily detected in BW-derived EVs, which demonstrates their clinical potential as a liquid-biopsy sample that may aid precise management, including assessment of the treatment response and drug resistance in patients with lung cancer.https://www.mdpi.com/2072-6694/12/10/2822lung cancerliquid biopsybronchial washing (BW)extracellular vesiclesEGFRT790M
spellingShingle Juhee Park
Chaeeun Lee
Jung Seop Eom
Mi-Hyun Kim
Yoon-Kyoung Cho
Detection of <i>EGFR</i> Mutations Using Bronchial Washing-Derived Extracellular Vesicles in Patients with Non-Small-Cell Lung Carcinoma
Cancers
lung cancer
liquid biopsy
bronchial washing (BW)
extracellular vesicles
EGFR
T790M
title Detection of <i>EGFR</i> Mutations Using Bronchial Washing-Derived Extracellular Vesicles in Patients with Non-Small-Cell Lung Carcinoma
title_full Detection of <i>EGFR</i> Mutations Using Bronchial Washing-Derived Extracellular Vesicles in Patients with Non-Small-Cell Lung Carcinoma
title_fullStr Detection of <i>EGFR</i> Mutations Using Bronchial Washing-Derived Extracellular Vesicles in Patients with Non-Small-Cell Lung Carcinoma
title_full_unstemmed Detection of <i>EGFR</i> Mutations Using Bronchial Washing-Derived Extracellular Vesicles in Patients with Non-Small-Cell Lung Carcinoma
title_short Detection of <i>EGFR</i> Mutations Using Bronchial Washing-Derived Extracellular Vesicles in Patients with Non-Small-Cell Lung Carcinoma
title_sort detection of i egfr i mutations using bronchial washing derived extracellular vesicles in patients with non small cell lung carcinoma
topic lung cancer
liquid biopsy
bronchial washing (BW)
extracellular vesicles
EGFR
T790M
url https://www.mdpi.com/2072-6694/12/10/2822
work_keys_str_mv AT juheepark detectionofiegfrimutationsusingbronchialwashingderivedextracellularvesiclesinpatientswithnonsmallcelllungcarcinoma
AT chaeeunlee detectionofiegfrimutationsusingbronchialwashingderivedextracellularvesiclesinpatientswithnonsmallcelllungcarcinoma
AT jungseopeom detectionofiegfrimutationsusingbronchialwashingderivedextracellularvesiclesinpatientswithnonsmallcelllungcarcinoma
AT mihyunkim detectionofiegfrimutationsusingbronchialwashingderivedextracellularvesiclesinpatientswithnonsmallcelllungcarcinoma
AT yoonkyoungcho detectionofiegfrimutationsusingbronchialwashingderivedextracellularvesiclesinpatientswithnonsmallcelllungcarcinoma